271 related articles for article (PubMed ID: 24321164)
1. Evaluating the effects of amantadin, modafinil and acetyl-L-carnitine on fatigue in multiple sclerosis--result of a pilot randomized, blind study.
Ledinek AH; Sajko MC; Rot U
Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S86-9. PubMed ID: 24321164
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
Tomassini V; Pozzilli C; Onesti E; Pasqualetti P; Marinelli F; Pisani A; Fieschi C
J Neurol Sci; 2004 Mar; 218(1-2):103-8. PubMed ID: 14759641
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study.
Rammohan KW; Rosenberg JH; Lynn DJ; Blumenfeld AM; Pollak CP; Nagaraja HN
J Neurol Neurosurg Psychiatry; 2002 Feb; 72(2):179-83. PubMed ID: 11796766
[TBL] [Abstract][Full Text] [Related]
4. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study.
Zifko UA; Rupp M; Schwarz S; Zipko HT; Maida EM
J Neurol; 2002 Aug; 249(8):983-7. PubMed ID: 12195441
[TBL] [Abstract][Full Text] [Related]
5. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
Stankoff B; Waubant E; Confavreux C; Edan G; Debouverie M; Rumbach L; Moreau T; Pelletier J; Lubetzki C; Clanet M;
Neurology; 2005 Apr; 64(7):1139-43. PubMed ID: 15824337
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.
Nourbakhsh B; Revirajan N; Morris B; Cordano C; Creasman J; Manguinao M; Krysko K; Rutatangwa A; Auvray C; Aljarallah S; Jin C; Mowry E; McCulloch C; Waubant E
Lancet Neurol; 2021 Jan; 20(1):38-48. PubMed ID: 33242419
[TBL] [Abstract][Full Text] [Related]
7. HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis.
Möller F; Poettgen J; Broemel F; Neuhaus A; Daumer M; Heesen C
Mult Scler; 2011 Aug; 17(8):1002-9. PubMed ID: 21561959
[TBL] [Abstract][Full Text] [Related]
8. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
Nourbakhsh B; Revirajan N; Waubant E
Contemp Clin Trials; 2018 Jan; 64():67-76. PubMed ID: 29113955
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis.
Yang TT; Wang L; Deng XY; Yu G
J Neurol Sci; 2017 Sep; 380():256-261. PubMed ID: 28870581
[TBL] [Abstract][Full Text] [Related]
10. Amantadine and the place of acupuncture in the treatment of fatigue in patients with multiple sclerosis: an observational study.
Foroughipour M; Bahrami Taghanaki HR; Saeidi M; Khazaei M; Sasannezhad P; Shoeibi A
Acupunct Med; 2013 Mar; 31(1):27-30. PubMed ID: 23151355
[TBL] [Abstract][Full Text] [Related]
11. Carnitine for fatigue in multiple sclerosis.
Tejani AM; Wasdell M; Spiwak R; Rowell G; Nathwani S
Cochrane Database Syst Rev; 2010 Feb; (2):CD007280. PubMed ID: 20166093
[TBL] [Abstract][Full Text] [Related]
12. Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis?
Ashtari F; Fatehi F; Shaygannejad V; Chitsaz A
Neurol Neurochir Pol; 2009; 43(5):428-32. PubMed ID: 20054744
[TBL] [Abstract][Full Text] [Related]
13. Carnitine for fatigue in multiple sclerosis.
Tejani AM; Wasdell M; Spiwak R; Rowell G; Nathwani S
Cochrane Database Syst Rev; 2012 May; 2012(5):CD007280. PubMed ID: 22592719
[TBL] [Abstract][Full Text] [Related]
14. Modafinil for multiple sclerosis fatigue: does it work?
Littleton ET; Hobart JC; Palace J
Clin Neurol Neurosurg; 2010 Jan; 112(1):29-31. PubMed ID: 19837509
[TBL] [Abstract][Full Text] [Related]
15. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
Yadav V; Marracci G; Kim E; Spain R; Cameron M; Overs S; Riddehough A; Li DK; McDougall J; Lovera J; Murchison C; Bourdette D
Mult Scler Relat Disord; 2016 Sep; 9():80-90. PubMed ID: 27645350
[TBL] [Abstract][Full Text] [Related]
16. Modafinil for the treatment of multiple sclerosis-related fatigue.
Brown JN; Howard CA; Kemp DW
Ann Pharmacother; 2010 Jun; 44(6):1098-103. PubMed ID: 20442351
[TBL] [Abstract][Full Text] [Related]
17. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.
Krupp LB; Coyle PK; Doscher C; Miller A; Cross AH; Jandorf L; Halper J; Johnson B; Morgante L; Grimson R
Neurology; 1995 Nov; 45(11):1956-61. PubMed ID: 7501140
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the efficacy of modafinil versus placebo in the treatment of multiple sclerosis fatigue.
Shangyan H; Kuiqing L; Yumin X; Jie C; Weixiong L
Mult Scler Relat Disord; 2018 Jan; 19():85-89. PubMed ID: 29175676
[TBL] [Abstract][Full Text] [Related]
19. Using modafinil to treat fatigue in Parkinson disease: a double-blind, placebo-controlled pilot study.
Lou JS; Dimitrova DM; Park BS; Johnson SC; Eaton R; Arnold G; Nutt JG
Clin Neuropharmacol; 2009; 32(6):305-10. PubMed ID: 19620846
[TBL] [Abstract][Full Text] [Related]
20. Amantadine influences cognitive processing in patients with multiple sclerosis.
Sailer M; Heinze HJ; Schoenfeld MA; Hauser U; Smid HG
Pharmacopsychiatry; 2000 Jan; 33(1):28-37. PubMed ID: 10721881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]